themedguru.com — Dr Doug Brown, Head of Biomedical Research at theMS Society, said, "Natalizumab is a licensed treatment for MS in the UK and we have known for some time that it reduces relapse rates and progression of disability in people with relapsing remitting MS; it’s nice to see these findings confirmed in this review.”
Oct 8, 2011 View in Crawl 4
No comments yet
It's quiet in here... can you hear the echo?